Dompé Farmaceutici S.p.a

This study tests a nasal spray called cenegermin (a lab-made nerve growth factor) to see if it can improve vision in people who recently lost sight due to a condition called NAION, which is like a stroke of the optic nerve. About 272 adults who had vision loss within the past two…

This study tests an eye drop containing a human nerve growth factor (cenegermin) to see if it can heal persistent corneal epithelial defects (PCED) — stubborn wounds on the eye's surface that won't close with standard treatments. About 150 adults with PCED for at least 14 days wi…

This study tests whether a new eye drop called DFL24498 can safely reduce the signs and symptoms of dry eye disease. About 417 adults with dry eye will use either the study drop or a placebo drop for 12 weeks. Researchers will measure changes in eye surface staining and dryness s…